- Home
- MCRB vs SKLZ Comparison
MCRB vs SKLZ Comparison
Compare MCRB & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- SKLZ
- Stock Information
- Founded
- MCRB 2010
- SKLZ 2012
- Country
- MCRB United States
- SKLZ United States
- Employees
- MCRB N/A
- SKLZ N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- SKLZ EDP Services
- Sector
- MCRB Health Care
- SKLZ Technology
- Exchange
- MCRB Nasdaq
- SKLZ Nasdaq
- Market Cap
- MCRB 165.3M
- SKLZ 136.4M
- IPO Year
- MCRB 2015
- SKLZ N/A
- Fundamental
- Price
- MCRB $15.91
- SKLZ $7.14
- Analyst Decision
- MCRB Hold
- SKLZ Buy
- Analyst Count
- MCRB 4
- SKLZ 1
- Target Price
- MCRB $73.67
- SKLZ $14.00
- AVG Volume (30 Days)
- MCRB 245.4K
- SKLZ 71.3K
- Earning Date
- MCRB 11-12-2025
- SKLZ 11-06-2025
- Dividend Yield
- MCRB N/A
- SKLZ N/A
- EPS Growth
- MCRB N/A
- SKLZ N/A
- EPS
- MCRB 10.22
- SKLZ N/A
- Revenue
- MCRB N/A
- SKLZ $93,320,000.00
- Revenue This Year
- MCRB N/A
- SKLZ $17.44
- Revenue Next Year
- MCRB N/A
- SKLZ $12.03
- P/E Ratio
- MCRB $1.62
- SKLZ N/A
- Revenue Growth
- MCRB N/A
- SKLZ N/A
- 52 Week Low
- MCRB $6.53
- SKLZ $3.54
- 52 Week High
- MCRB $24.67
- SKLZ $9.11
- Technical
- Relative Strength Index (RSI)
- MCRB 44.26
- SKLZ 37.95
- Support Level
- MCRB $17.00
- SKLZ $7.21
- Resistance Level
- MCRB $24.67
- SKLZ $7.54
- Average True Range (ATR)
- MCRB 2.01
- SKLZ 0.29
- MACD
- MCRB -0.50
- SKLZ -0.19
- Stochastic Oscillator
- MCRB 15.94
- SKLZ 3.67
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.